ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
科倫博泰生物-B
503.500
+6.500
1.31%
手動刷新
成交量:
85.63萬
成交額:
4.28億
市值:
1,174.09億
市盈率:
-267.67
高:
508.000
開:
481.000
低:
481.000
收:
497.000
52周最高:
581.000
52周最低:
228.200
股本:
2.33億
香港流通股本:
1.63億
量比:
1.26
換手率:
0.53%
股息:
- -
股息率:
- -
每股收益(LYR):
-1.881
淨資產收益率:
-9.34%
總資產收益率:
-4.26%
市淨率:
21.25
市盈率(LYR):
-267.67
市銷率:
50.25
資料載入中...
總覽
公司
新聞資訊
公告
醫保引路,企業破局——從科倫博泰看創新藥的「中國路徑」
中国财富网
·
2025/12/19
每日沽空追蹤 | 科倫博泰生物-B 12月19日沽空量成交3.89萬股,沽空比例為8.64%
市场透视
·
2025/12/19
科倫博泰生物-B12月19日獲主力加倉849.8萬元
市场透视
·
2025/12/19
醫藥股集體走高 藥明生物(02269)漲5.93% 機構料明年板塊穩中向好態勢延續
金吾财讯
·
2025/12/19
兩家知名創新藥研發公司就侵犯商業秘密等達成和解
界面
·
2025/12/18
每日沽空追蹤 | 科倫博泰生物-B 12月17日沽空量成交1.35萬股,沽空比例為4.66%
市场透视
·
2025/12/17
【灣區早參】香港最新失業率維持3.8%;澳門全年旅客數量或達3900萬人次
金吾财讯
·
2025/12/17
科倫博泰生物(06990.HK)與宜聯生物方訂立和解協議
阿斯达克财经
·
2025/12/16
科倫博泰生物-B與Medilink Therapeutics (Suzhou)等達成和解協議
美股速递
·
2025/12/16
科倫博泰生物-B(06990.HK)獲匯添富基金增持25.14萬股
中金财经
·
2025/12/16
科倫博泰生物-B(06990):三款產品獲納入國家醫保目錄
智通财经
·
2025/12/15
每日沽空追蹤 | 科倫博泰生物-B 12月15日沽空量成交5.15萬股,沽空比例為4.68%
市场透视
·
2025/12/15
恒生醫療保健指數跌幅擴大至2.75% 醫藥股普遍走低 科倫博泰生物(06990)跌超7%
金吾财讯
·
2025/12/15
四川大力發展醫藥創新產業,政策組合拳效應已逐漸顯現!
制药网
·
2025/12/15
醫藥生物2026年創新藥投資邏輯:以DE-RISKING路徑鎖定創新藥高成長機會
天风证券
·
2025/12/14
博度曲妥珠單抗:已獲批二線及以上治療乳腺癌,涵蓋三線適應症人群
医药笔记
·
2025/12/12
國產之光,科倫博泰HER2 ADC突圍二線及以上全人群HER2陽性乳腺癌
药械Talks
·
2025/12/12
科倫藥業控股子公司科倫博泰擬推2025年股份激勵計劃
中访网数据
·
2025/12/12
港股2026:從「窪地修復」走向「新質成長」的價值重估
金吾财讯
·
2025/12/12
中金:維持科倫博泰生物-B(06990)跑贏行業評級 目標價550港元
智通财经
·
2025/12/12
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06990/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科倫博泰生物-B","latestPrice":503.5,"timestamp":1775117301007,"preClose":497,"halted":0,"volume":856267,"delay":0,"changeRate":0.013078470824949699,"floatShares":162769979,"shares":233185969,"eps":-1.881013718661097,"marketStatus":"已收盤","change":6.5,"latestTime":"04-02 16:08:21","open":481,"high":508,"low":481,"amount":427890983,"amplitude":0.054326,"askPrice":503.5,"askSize":12200,"bidPrice":502,"bidSize":1700,"shortable":3,"etf":0,"ttmEps":-1.881013718661097,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":5,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":497,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":1.26347,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-4.26%","roe":"-9.34%","lyrEps":-1.881014,"volumeRatio":1.26347,"shares":233185969,"dividePrice":0,"high":508,"amplitude":0.054326,"preClose":497,"low":481,"week52Low":228.2,"pbRate":"21.25","psRate":"50.25","week52High":581,"institutionHeld":0,"latestPrice":503.5,"committee":-0.755396,"eps":-1.881013718661097,"divideRate":0,"volume":856267,"delay":0,"ttmEps":-1.881013718661097,"open":481,"prevYearClose":392.2,"prevWeekClose":457.6,"prevMonthClose":460,"prevQuarterClose":460,"fiveDayClose":427.4,"twentyDayClose":369.8,"sixtyDayClose":432},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.6316,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6316,"analysts":19,"updateTime":1774540800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-04-01","current":-265.49755,"percent":0.060921,"low":-351.800852,"twenty":-172.20913,"median":-125.040793,"eighty":-50.917117,"high":-21.029201,"avg":-127.409086,"sd":77.323333,"marketCap":115893442000},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-01","current":-266.039517,"twenty":-172.20913,"median":-125.040793,"eighty":-50.917117,"marketCap":115893442000}],"updateTime":1775117011869},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592417196","title":"醫保引路,企業破局——從科倫博泰看創新藥的「中國路徑」","url":"https://stock-news.laohu8.com/highlight/detail?id=2592417196","media":"中国财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592417196?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 18:24","pubTimestamp":1766139849,"startTime":"0","endTime":"0","summary":"日前,2025年国家医保药品目录调整工作圆满收官。科伦博泰总经理葛均友表示。“今年纳入医保的创新药共同特征是:填补临床空白、同类最优、更具性价比。”医保谈判桌前的一来一往,实质上是国家医疗需求与企业创新方向的对齐过程。在这条道路上,每一次双向奔赴,都在让“健康中国”的愿景更加清晰可见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219182632a45fad9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219182632a45fad9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06978","BK1574","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592964561","title":"每日沽空追蹤 | 科倫博泰生物-B 12月19日沽空量成交3.89萬股,沽空比例為8.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592964561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592964561?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 16:30","pubTimestamp":1766133037,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间12月19日,涨3.51%,卖空量成交3.89万股,较上一交易日减少40.61%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163646a45f388c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163646a45f388c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592196453","title":"科倫博泰生物-B12月19日獲主力加倉849.8萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592196453","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592196453?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 16:15","pubTimestamp":1766132149,"startTime":"0","endTime":"0","summary":"12月19日, 科伦博泰生物-B股价涨3.51%,报收419.20元,成交金额2.2亿元,换手率0.32%,振幅6.96%,量比0.77。科伦博泰生物-B今日主力资金净流入849.8万元,上一交易日主力净流入388.5万元。该股近5个交易日下跌2.42%,主力资金累计净流入2883.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入9573.5万元,其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162021a45f2374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162021a45f2374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592044139","title":"醫藥股集體走高 藥明生物(02269)漲5.93% 機構料明年板塊穩中向好態勢延續","url":"https://stock-news.laohu8.com/highlight/detail?id=2592044139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592044139?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 10:23","pubTimestamp":1766111038,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股集体走高,药明生物 涨5.93%,药明合联涨4.56%,君实生物涨4.54%,康诺亚-B涨4.19%,荣昌生物涨3.98%,科伦博泰生物-B涨4.00%,泰格医药涨4.30%,复宏汉霖涨3.72%,诺诚健华涨3.26%。交银国际发布医药行业周报,展望2026年,该机构认为板块稳中向好态势延续,但影响市场表现的核心因素或呈分化态势,后续选股逻辑或将重回基本面和估值,即关注存在基本面预期差、当前仍被低估的个股。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971870","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","02696","03347","LU0052750758.USD","LU0196878994.USD","LU0348735423.USD","LU0359201612.USD","02268","LU0588546209.SGD","159938","BK1521","LU0348825331.USD","SG9999002562.SGD","LU0823426480.USD","BK1574","BK1610","LU0417516902.SGD","LU0051755006.USD","IE00B0JY6N72.USD","LU1242518857.USD","LU2328871848.SGD","HK0000165453.HKD","LU0856984785.SGD","SG9999014674.SGD","LU1688375341.USD","06990","02269","01877","BK1576","LU0039217434.USD","BK1161","LU0417516738.SGD","BK1141","LU1242518931.SGD","LU0819121731.USD","LU0326950275.SGD","LU0181495838.USD","09939","LU0823426308.USD","LU0359202008.SGD","BK1587","02162","LU2488822045.USD","LU0327786744.USD","09969","09995","LU1969619763.USD","LU0516422366.SGD","LU0572944931.SGD","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592904600","title":"兩家知名創新藥研發公司就侵犯商業秘密等達成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904600","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592904600?lang=zh_tw&edition=fundamental","pubTime":"2025-12-18 09:43","pubTimestamp":1766022202,"startTime":"0","endTime":"0","summary":"企业公告还显示,科伦博泰于2024年对宜联生物方提起刑事控告,并于今年就涉嫌侵犯商业秘密、涉嫌损害公司利益发起民事诉讼。科伦博泰在公告中提出,此次和解不会对其财务状况及营运造成任何重大不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218094528a6b02fb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218094528a6b02fb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","06978","LU0196878994.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592441339","title":"每日沽空追蹤 | 科倫博泰生物-B 12月17日沽空量成交1.35萬股,沽空比例為4.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592441339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592441339?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 16:30","pubTimestamp":1765960237,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间12月17日,涨0.54%,卖空量成交1.35万股,较上一交易日减少90.28%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163631a4561544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163631a4561544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592495994","title":"【灣區早參】香港最新失業率維持3.8%;澳門全年旅客數量或達3900萬人次","url":"https://stock-news.laohu8.com/highlight/detail?id=2592495994","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592495994?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 08:37","pubTimestamp":1765931872,"startTime":"0","endTime":"0","summary":"永久性残疾类别个案保持平稳,有1.6406万宗。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971667","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00123","BK1538","BK1136","BK1240","BK1594","01898","BK1178","LU1171460220.USD","LU0572944931.SGD","BK1584","LU0456846285.SGD","LU0327786744.USD","06990","LU0051755006.USD","LU1655091616.SGD","BK1550","BK1161","02601","LU0196878994.USD","LU0588546209.SGD","IE00B543WZ88.USD","BK1521","BK1555","LU0456827905.SGD","LU0228659784.USD","LU0307460666.USD","SG9999001226.SGD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591980375","title":"科倫博泰生物(06990.HK)與宜聯生物方訂立和解協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2591980375","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591980375?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 22:03","pubTimestamp":1765893780,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(06990.HK) 公布,12月16日,公司与宜联生物方(宜联生物医药、薛彤彤博士、肖亮博士及蔡家强博士)订立和解协议,解决公司对宜联生物方提起的若干争议。根据协议,宜联生物医药应就宜联生物医药管线中YL201、YL202、YL211、YL212、YL221及YL222于和解生效日期前通过对外授权所产生;及于和解生效日期后通过对外授权及未来销售 所产生的收入及净利润与公司分享一定比例。2025年,公司就涉嫌侵犯商业秘密及涉嫌损害公司利益对宜联生物方发起两项民事诉讼。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-12-16 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1490772/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1490772/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176147930","title":"科倫博泰生物-B與Medilink Therapeutics (Suzhou)等達成和解協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1176147930","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176147930?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 20:36","pubTimestamp":1765888569,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B与Medilink Therapeutics (Suzhou)等达成和解协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591567851","title":"科倫博泰生物-B(06990.HK)獲匯添富基金增持25.14萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591567851","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591567851?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 07:47","pubTimestamp":1765842423,"startTime":"0","endTime":"0","summary":"格隆汇12月16日丨根据联交所最新权益披露资料显示,2025年12月10日,科伦博泰生物-B(06990.HK)获汇添富基金管理股份有限公司在场内以每股均价410.0671港元增持25.14万股,涉资约1.03亿港元。\r\n\r\n 增持后,汇添富基金管理股份有限公司最新持股数目为831.83万股,持股比例由4.96%上升至5.11%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/16/20251216378127.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/16/20251216378127.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251216/31867227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591142649","title":"科倫博泰生物-B(06990):三款產品獲納入國家醫保目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2591142649","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591142649?lang=zh_tw&edition=fundamental","pubTime":"2025-12-15 21:03","pubTimestamp":1765803821,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科伦博泰生物-B(06990)发布公告,本公司三款产品,即ADC Sacituzumab Tirumotecan(sac-TMT,亦称SKB264/MK-2870)(商品名:佳泰莱®)、西妥昔单抗N01注射液(前称A140)(商品名:达泰莱®)及Tagitanlimab(亦称A167)(商品名:科泰莱®),已获纳入国家医疗保障局及中国人力资源和社会保障部于2025年12月7日公布的国家医保目录。值得注意的是,ADC Sacituzumab Tirumotecan有两项适应症获纳入国家医保目录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科伦博泰生物-B(06990):三款产品获纳入国家医保目录","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591661614","title":"每日沽空追蹤 | 科倫博泰生物-B 12月15日沽空量成交5.15萬股,沽空比例為4.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591661614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591661614?lang=zh_tw&edition=fundamental","pubTime":"2025-12-15 16:30","pubTimestamp":1765787437,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间12月15日,跌8.21%,卖空量成交5.15万股,较上一交易日减少72.24%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163625a44d4363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163625a44d4363&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591691376","title":"恒生醫療保健指數跌幅擴大至2.75% 醫藥股普遍走低 科倫博泰生物(06990)跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591691376","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591691376?lang=zh_tw&edition=fundamental","pubTime":"2025-12-15 11:11","pubTimestamp":1765768311,"startTime":"0","endTime":"0","summary":"金吾财讯 | 恒生医疗保健指数跌幅扩大至2.75%,医药股普遍走低,科伦博泰生物(06990)跌7.07%,百济神州(06160)跌5.35%,复宏汉霖(02696)跌5.32%,荣昌生物(09995)跌4.05%,康方生物(09926)跌3.61%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971535","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU2328871848.SGD","BK1588","LU0196878994.USD","LU1720050803.USD","159938","LU1303224171.USD","LU2399975544.HKD","HK0000165453.HKD","LU2476274720.SGD","IE00B543WZ88.USD","LU0634319403.HKD","09995","06990","LU1719994722.HKD","LU0417516902.SGD","LU2488822045.USD","BK1500","LU1969619763.USD","LU0417516571.SGD","LU0348827113.USD","LU2476274308.USD","LU0348784397.USD","02696","IE00B5MMRT66.SGD","LU0561508036.HKD","BK1583","LU1794554557.SGD","BK1515","LU0348766576.USD","LU2778985437.USD","09926","LU0417516738.SGD","LU1251922891.USD","IE00BPRC5H50.USD","LU0588546209.SGD","LU0307460666.USD","LU0348825331.USD","09939","159506","LU1770034418.SGD","LU0540923850.HKD","06160","LU1961090484.USD","LU0348735423.USD","LU0348767384.USD","BK1161","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591614698","title":"四川大力發展醫藥創新產業,政策組合拳效應已逐漸顯現!","url":"https://stock-news.laohu8.com/highlight/detail?id=2591614698","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591614698?lang=zh_tw&edition=fundamental","pubTime":"2025-12-15 07:01","pubTimestamp":1765753296,"startTime":"0","endTime":"0","summary":"5月,四川省出台并实施了《四川省促进医药健康产业发展若干措施》。未来,随着政策组合拳效应的逐渐显现,从研发到应用全链条的打通,四川医药产业创新发展将迈上一个新阶段。近年来,四川省一直在积极制定推动创新药发展的相关政策,支持创新药技术攻关、生产制造、临床应用。未来,随着《四川省支持生物医药和医疗器械产业高质量发展若干政策措施》等新政策的不断落地执行,预计 2025 年底前医药健康产业营收将突破4000亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215070140a6a26739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215070140a6a26739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU0196878994.USD","BK1574","BK1161","09939","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591865274","title":"醫藥生物2026年創新藥投資邏輯:以DE-RISKING路徑鎖定創新藥高成長機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2591865274","media":"天风证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591865274?lang=zh_tw&edition=fundamental","pubTime":"2025-12-14 00:00","pubTimestamp":1765641600,"startTime":"0","endTime":"0","summary":"中国将持续涌现高质量创新药中国创新药行业已初步形成以龙头企业为引领,大批量优质企业为骨干的金字塔梯队,产学研持续加深合作,产业项目储备多。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214141231a449435c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214141231a449435c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","02105","BK1574","LU2097828557.USD","06160","LU2097828714.EUR","LU2328871848.SGD","09969","HK0000165453.HKD","LU0455707207.USD","LU2097828631.EUR","01167","LU0502904849.HKD","BK1161","02552","LU2097828805.USD","02171","LU1969619763.USD","06978","BK1583","BK1589","02616","06990","01801","LU2097828474.EUR","LU2488822045.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590508581","title":"博度曲妥珠單抗:已獲批二線及以上治療乳腺癌,涵蓋三線適應症人群","url":"https://stock-news.laohu8.com/highlight/detail?id=2590508581","media":"医药笔记","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590508581?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 17:17","pubTimestamp":1765531030,"startTime":"0","endTime":"0","summary":"值得注意的是,今年10月,博度曲妥珠单抗已获批治疗二线及以上HER2 阳性乳腺癌,成为首个覆盖该适应症二线及以上全人群的国产HER2 ADC药物,为中国晚期 HER2 阳性乳腺癌患者带来全新治疗选择。据悉,在博度曲妥珠单抗进行上市申请申报的过程中,先后提交了两个适应症申请:分别针对三线及以上,以及二线及以上HER2阳性乳腺癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212174847a44490e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212174847a44490e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590085555","title":"國產之光,科倫博泰HER2 ADC突圍二線及以上全人群HER2陽性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2590085555","media":"药械Talks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590085555?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 16:36","pubTimestamp":1765528617,"startTime":"0","endTime":"0","summary":"根据获批适应症,博度曲妥珠单抗将用于既往接受过一种或一种以上抗HER2药物治疗的不可切除或转移性HER2阳性成人乳腺癌患者。虽然在博度曲妥珠单抗之前,已有两款国产HER2 ADC拿到上市许可。所以,博度曲妥珠单抗是首个真正意义上实现HER2阳性乳腺癌二线及以上治疗全面覆盖的国产HER2 ADC。要进一步说明的是,在博度曲妥珠单抗进行NDA申报的过程中,先后提交了两个适应症申请:分别针对三线及以上,以及二线及以上HER2阳性乳腺癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212164453a4446707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212164453a4446707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590371508","title":"科倫藥業控股子公司科倫博泰擬推2025年股份激勵計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2590371508","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590371508?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 13:30","pubTimestamp":1765517418,"startTime":"0","endTime":"0","summary":"中访网数据 四川科伦药业股份有限公司于12月12日发布公告,其控股子公司四川科伦博泰生物医药股份有限公司计划实施2025年股份激励计划。科伦药业表示,即使按此上限全额发行,其持有科伦博泰的股权比例也不会发生重大变化,科伦博泰仍为其控股子公司。目前,该激励计划已获得科伦博泰董事会审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212134240a4440641&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212134240a4440641&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590529993","title":"港股2026:從「窪地修復」走向「新質成長」的價值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2590529993","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590529993?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 10:51","pubTimestamp":1765507865,"startTime":"0","endTime":"0","summary":"公司股价从今年4月份的低位3.36港元一路攀升至12月10日的9.3港元,涨幅超170%,是港股市场中“估值修复+价值回归”的代表性标的之一。2026年“重估”和宏观或主导方向建银国际在2026年投资展望中指出,港股投资逻辑已从传统的估值修复,转变为基于新质生产力和高质量发展的估值重估。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971449","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","06990","06616","BK1129","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590247523","title":"中金:維持科倫博泰生物-B(06990)跑贏行業評級 目標價550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590247523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590247523?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 09:16","pubTimestamp":1765502219,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研报称,考虑到科伦博泰生物-B授权首付款收入,基本保持2026年归母净利润预测不变。该行维持跑赢行业评级,基于DCF模型,维持目标价550港币,较当前股价有33.4%的上行空间。该行认为SKB105作为临床前阶段的新兴靶点ADC资产,本次达成对外授权,给公司带来较好的现金流入的同时也助力其临床开发路径进入快车道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}